101 Sleep To preface, the relationship between sleep patterns and MASLD is complex
The following sources are referenced in this article: Brito, Sci Rep 2022 Choi, Ann Dermatol 2016 Eisenberg, Nat Med 2018 Han, Biomed Res Int 2015 Haroon, Biomedicines 2023 Kiechl, Am J Clin Nutr 2018 Ko, CrystEngComm 2013 Lei, Evid Based Complement Alternat Med 2015 Madeo, Autophagy 2018 No authors listed, Nutr Rev 1946 Noppakun, Arch Dermatol 1986 Panhard, Br J Dermatol 2012 Pasricha, Indian J Dermatol Venereol Leprol 1981 Pasricha, Indian J Dermatol Venereol Leprol 1986 Roy, J Sex Med 2008 Sehrawat, Pigment Int 2017 Sieve, Science 1941 Wood, FASEB J 2009 Yale, Skin Appendage Disord 2020 Zarafonetis, J Invest Dermatol 1950 Join over 300,000 people on our weekly email list.

Microdosing may be a fit for women who: Are in perimenopause or menopause and experiencing weight changes, increased cravings, or energy dips Want a gentle, adjustable approach to GLP-1 therapy Prefer pairing medication with lifestyle strategies (nutrition, strength training, hormone therapy) Have no major contraindications to GLP-1 medications When Were More Cautious We may recommend holding off or exploring other options if you have: A personal or family history of medullary thyroid carcinoma or MEN2 A history of pancreatitis Significant gastrointestinal disorders that may be worsened by GLP-1 use Protecting Muscle & Metabolic Health While on GLP1 One of the biggest concerns with any weight-management medication is the potential loss of lean muscle mass
Format: Powder (salt form) Compound class: Small molecule (NNMT inhibitor)